JD BioWorks Research Resources
Research Library
Source-conscious guides to analytical methods, documentation, compound literature, regulatory developments, and evidence interpretation.
Browse articles by month, topic, or compound
Filtered Research
14 articles
Is Zenagamtide in Phase 2 Human Trials? What the 2026 Data Actually Show
A review of oral and subcutaneous zenagamtide reports from one Phase 2 study, including the study population, outcomes, and limitations.
Read article
MOTS-MET Trial Record: What NCT07505745 Shows—and What It Does Not
A Phase 2a MOTS-c study is listed as recruiting on ClinicalTrials.gov. Here is what the registry confirms—and what it does not prove.
Read article
The FDA Received 990 Reports About Compounded Semaglutide—But Social Media Is Reading the Number Wrong
FDA received 990 adverse-event reports associated with compounded semaglutide. Learn what the number shows—and why it does not prove causation or risk.
Read article
FDA Generic Peptide Guidance 2026: What Changed?
An overview of FDA's July 2026 revised draft peptide guidances and what they mean for generic drug development.
Read article
FDA Peptide Compounding Vote: What It Actually Means
A guide to the July 2026 peptide-compounding advisory votes and the difference between committee recommendations and FDA approval.
Read articleRESEARCH RESOURCE PATHWAY
Compound research evidence library
Browse research-only literature overviews organized by exact compound name. Each page separates reported findings from analytical identity and evidence limitations.
BPC-157 research evidence
A source-conscious overview of preclinical evidence and study limitations.
GHK-Cu research evidence
Research context for GHK-Cu, terminology, methods, and study limitations.
KPV research evidence
Research context, sequence identity, documentation, and evidence limitations.
MOTS-C research evidence
Research context for a mitochondrial-derived peptide and its documentation needs.
PT-141 research evidence
A research-only review of nomenclature, identity, literature, and limitations.
Selank research evidence
Research context, peptide identity, sourcing records, and evidence limits.
TB-500 research evidence
Clarify nomenclature, sequence claims, laboratory identity, and source limitations.
Tesamorelin research evidence
Research context, identity documentation, analytical methods, and evidence limits.
RESEARCH RESOURCE PATHWAY
Research and editorial standards
See how sources, corrections, and document revisions are handled.
Scientific sourcing and editorial standards
How JD BioWorks selects sources, distinguishes evidence levels, and updates research content.
Corrections and document revision policy
How factual corrections, material updates, and superseded records are handled.
START WITH THE RESEARCH QUESTION